| Disease Name filter_list |
Disease Category filter_list |
DSI* filter_list |
DPI** filter_list |
| Alloxan Diabetes |
Nutritional and Metabolic Diseases ; Endocrine System Diseases ; |
0.459 |
0.724 |
| Alzheimer's Disease |
Nervous System Diseases ; Mental Disorders ; |
0.459 |
0.724 |
| Presenile dementia |
Nervous System Diseases ; Mental Disorders ; |
0.459 |
0.724 |
| Diabetes Mellitus, Experimental |
Nutritional and Metabolic Diseases ; Endocrine System Diseases ; |
0.459 |
0.724 |
| Diabetes Mellitus, Non-Insulin-Dependent |
Nutritional and Metabolic Diseases ; Endocrine System Diseases ; |
0.459 |
0.724 |
| Diabetic Neuropathies |
Nervous System Diseases ; Endocrine System Diseases ; |
0.459 |
0.724 |
| Drug abuse |
Chemically-Induced Disorders ; Mental Disorders ; |
0.459 |
0.724 |
| Drug habituation |
Chemically-Induced Disorders ; Mental Disorders ; |
0.459 |
0.724 |
| Drug Use Disorders |
Chemically-Induced Disorders ; Mental Disorders ; |
0.459 |
0.724 |
| Hyperalgesia |
Nervous System Diseases ; Pathological Conditions, Signs and Symptoms ; |
0.459 |
0.724 |
| Hyperglycemia |
Nutritional and Metabolic Diseases ; |
0.459 |
0.724 |
| Hyperinsulinism |
Nutritional and Metabolic Diseases ; |
0.459 |
0.724 |
| Insulin Resistance |
Nutritional and Metabolic Diseases ; |
0.459 |
0.724 |
| Lung diseases |
Respiratory Tract Diseases ; |
0.459 |
0.724 |
| Organic Mental Disorders, Substance-Induced |
Chemically-Induced Disorders ; Mental Disorders ; |
0.459 |
0.724 |
| Osteogenesis Imperfecta |
Musculoskeletal Diseases ; Congenital, Hereditary, and Neonatal Diseases and Abnormalities ; Skin and Connective Tissue Diseases ; |
0.459 |
0.724 |
| Parkinson Disease |
Nervous System Diseases ; |
0.459 |
0.724 |
| Streptozotocin Diabetes |
Nutritional and Metabolic Diseases ; Endocrine System Diseases ; |
0.459 |
0.724 |
| Substance Dependence |
Chemically-Induced Disorders ; Mental Disorders ; |
0.459 |
0.724 |
| Substance Use Disorders |
Chemically-Induced Disorders ; Mental Disorders ; |
0.459 |
0.724 |
| Congenital diaphragmatic hernia |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities ; Pathological Conditions, Signs and Symptoms ; |
0.459 |
0.724 |
| Substance-Related Disorders |
Chemically-Induced Disorders ; Mental Disorders ; |
0.459 |
0.724 |
| Donohue Syndrome |
Musculoskeletal Diseases ; Congenital, Hereditary, and Neonatal Diseases and Abnormalities ; Nutritional and Metabolic Diseases ; Endocrine System Diseases ; |
0.459 |
0.724 |
| Congenital hernia of foramen of Morgagni |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities ; Pathological Conditions, Signs and Symptoms ; |
0.459 |
0.724 |
| Congenital hernia of foramen of Bochdalek |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities ; Pathological Conditions, Signs and Symptoms ; |
0.459 |
0.724 |
| Impaired glucose tolerance |
Nutritional and Metabolic Diseases ; |
0.459 |
0.724 |
| Symmetric Diabetic Proximal Motor Neuropathy |
Nervous System Diseases ; Endocrine System Diseases ; |
0.459 |
0.724 |
| Asymmetric Diabetic Proximal Motor Neuropathy |
Nervous System Diseases ; Endocrine System Diseases ; |
0.459 |
0.724 |
| Diabetic Mononeuropathy |
Nervous System Diseases ; Endocrine System Diseases ; |
0.459 |
0.724 |
| Diabetic Polyneuropathies |
Nervous System Diseases ; Endocrine System Diseases ; |
0.459 |
0.724 |
| Diabetic Amyotrophy |
Nervous System Diseases ; Endocrine System Diseases ; |
0.459 |
0.724 |
| Diabetic Autonomic Neuropathy |
Nervous System Diseases ; Endocrine System Diseases ; |
0.459 |
0.724 |
| Insulin Receptor, Defect in |
Musculoskeletal Diseases ; Congenital, Hereditary, and Neonatal Diseases and Abnormalities ; Nutritional and Metabolic Diseases ; Endocrine System Diseases ; |
0.459 |
0.724 |
| Rabson-Mendenhall Syndrome |
Musculoskeletal Diseases ; Congenital, Hereditary, and Neonatal Diseases and Abnormalities ; Nutritional and Metabolic Diseases ; Endocrine System Diseases ; |
0.459 |
0.724 |
| Familial Alzheimer Disease (FAD) |
Nervous System Diseases ; Mental Disorders ; |
0.459 |
0.724 |
| Gastric Adenocarcinoma |
N/A |
0.459 |
0.724 |
| Diabetes Mellitus, Insulin-Resistant, with Acanthosis Nigricans |
Skin and Connective Tissue Diseases ; Nutritional and Metabolic Diseases ; Endocrine System Diseases ; |
0.459 |
0.724 |
| Insulin resistance - type A |
N/A |
0.459 |
0.724 |
| Diabetic Asymmetric Polyneuropathy |
Nervous System Diseases ; Endocrine System Diseases ; |
0.459 |
0.724 |
| Allodynia |
Nervous System Diseases ; Pathological Conditions, Signs and Symptoms ; |
0.459 |
0.724 |
| Alzheimer Disease, Late Onset |
Nervous System Diseases ; Mental Disorders ; |
0.459 |
0.724 |
| Acute Confusional Senile Dementia |
Nervous System Diseases ; Mental Disorders ; |
0.459 |
0.724 |
| Substance abuse problem |
Chemically-Induced Disorders ; Mental Disorders ; |
0.459 |
0.724 |
| Alzheimer's Disease, Focal Onset |
Nervous System Diseases ; Mental Disorders ; |
0.459 |
0.724 |
| Alzheimer Disease, Early Onset |
Nervous System Diseases ; Mental Disorders ; |
0.459 |
0.724 |
| Diabetic Neuralgia |
Nervous System Diseases ; Endocrine System Diseases ; |
0.459 |
0.724 |
| Hyperalgesia, Primary |
Nervous System Diseases ; Pathological Conditions, Signs and Symptoms ; |
0.459 |
0.724 |
| Hyperalgesia, Secondary |
Nervous System Diseases ; Pathological Conditions, Signs and Symptoms ; |
0.459 |
0.724 |
| Tactile Allodynia |
Nervous System Diseases ; Pathological Conditions, Signs and Symptoms ; |
0.459 |
0.724 |
| Hyperalgesia, Thermal |
Nervous System Diseases ; Pathological Conditions, Signs and Symptoms ; |
0.459 |
0.724 |
| Lewy Body Disease |
Nervous System Diseases ; Mental Disorders ; |
0.459 |
0.724 |
| Insulin Sensitivity |
Nutritional and Metabolic Diseases ; |
0.459 |
0.724 |
| Endogenous Hyperinsulinism |
Nutritional and Metabolic Diseases ; |
0.459 |
0.724 |
| Exogenous Hyperinsulinism |
Nutritional and Metabolic Diseases ; |
0.459 |
0.724 |
| Compensatory Hyperinsulinemia |
Nutritional and Metabolic Diseases ; |
0.459 |
0.724 |
| Drug Dependence |
Chemically-Induced Disorders ; Mental Disorders ; |
0.459 |
0.724 |
| INSULIN RESISTANCE, SUSCEPTIBILITY TO |
N/A |
0.459 |
0.724 |
| Hyperglycemia, Postprandial |
Nutritional and Metabolic Diseases ; |
0.459 |
0.724 |
| Hyperinsulinemic Hypoglycemia, Familial, 5 |
Nutritional and Metabolic Diseases ; |
0.459 |
0.724 |
| Mechanical Allodynia |
Nervous System Diseases ; Pathological Conditions, Signs and Symptoms ; |
0.459 |
0.724 |
| Intellectual Disability |
Nervous System Diseases ; Pathological Conditions, Signs and Symptoms ; Behavior and Behavior Mechanisms ; Mental Disorders ; |
0.459 |
0.724 |
| DIABETES MELLITUS, TYPE 2, PROTECTION AGAINST |
N/A |
0.459 |
0.724 |
| Prescription Drug Abuse |
Chemically-Induced Disorders ; Mental Disorders ; |
0.459 |
0.724 |
| NO RESULT FOUND |